中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 8
Aug.  2016
Turn off MathJax
Article Contents

Synergistic effect of interventing insulin-like growth factor-Ⅰ receptor activation combined with anti-cancer drugs in inhibiting the proliferation of hepatocellular carcinoma cells

DOI: 10.3969/j.issn.1001-5256.2016.08.022
Research funding:

 

  • Received Date: 2016-03-18
  • Published Date: 2016-08-20
  • Objective To investigate the intervention of gene transcription of insulin- like growth factor- Ⅰ receptor( IGF- ⅠR) and its synergistic effect with anti- cancer drugs in inhibiting the proliferation of hepatocellular carcinoma( HCC) cells. Methods The HBV-positive HCC PLC / PRF /5 and HBV- negative Bel- 7404 cells were transfected with the efficient plasmid p GPU6 / GFP / Neo- IGF- ⅠR-shRNA. Fluorescent quantitative RT- PCR and Western blot were used to measure mRNA and protein expression,the Cell Counting Kit-8 was used to analyze cell proliferation,and flow cytometry and Annexin- V- PE /7- ADD were used to analyze cell cycle and apoptosis.The t- test was used for comparison of continuous data between groups,the Fisher's exact test was used for comparison of categorical data between groups. Results The efficiency of IGF-ⅠR shRNA transfection was 71% in HCC PLC / PRF /5 cells and 90% in Bel- 7404 cells,and both cells showed reductions in the mRNA and protein expression of IGF- ⅠR. The intervention group showed a significant inhibition compared with the negative control group,and the 72- hour inhibition rates of Bel- 7404 cells and PLC / PRF /5 cells showed significant differences between the two groups( inhibition rates of Bel- 7404 cells: 61. 5% ± 1. 7% vs 11. 2% ± 0. 9%,t = 5. 493,P < 0. 05; inhibition rates of PLC / PRF /5 cells: 63. 9% ± 3. 9% vs 9. 5% ± 1. 1%,t = 19. 244,P < 0. 001). The intervention group showed a significantly higher apoptosis rate of Bel- 7404 cells than the blank control group( 35. 96% vs 12. 16%,P < 0. 001) and the negative control group( 35. 96% vs 9. 43%,P < 0. 001),as well as a significantly higher apoptosis rate of PLC/PRF/5 cells than the blank control group( 44. 84% vs 6. 62%,P < 0. 001) and the negative control group( 44. 84% vs 4. 02%,P < 0. 001). The co- intervention group showed significantly higher percentages of Bel- 7404 cells and PLC / PRF /5 cells in G0/ G1 phase than the negative control group( 59. 0% ± 1. 3%vs 48. 4% ± 0. 8%,t = 12. 032,P < 0. 001; 65. 4% ± 0. 5% vs 53. 5% ± 0. 7%,t = 22. 789,P < 0. 001). The co- intervention group showed significantly lower expression of cyclin D1 in Bel- 7404 cells and PLC / PRF /5 cells than the negative control group( 59. 6% ± 4. 7%vs 90. 0% ± 3. 4%,t = 7. 389,P < 0. 05; 39. 9% ± 0. 5% vs 90. 2% ± 14. 6%,t = 4. 876,P < 0. 05). The OD value of Bel- 7404 cells and PLC / PRF /5 cells showed a significant difference between the intervention group and the negative control group when the sorafenib concentration was 0,2. 5,5,10,and 20 nmol / L and the oxaliplatin concentration was 0,5,10,20,and 40 μmol / L( all P < 0. 05). Conclusion The downregulation of IGF-ⅠR gene transcription has the synergistic effect of inhibiting HCC cell proliferation and improving drug susceptibility.

     

  • loading
  • [1]GILLET JP,ANDERSEN JB,MADIGAN JP,et al.A gene expression signature associated with overall survival in patients with hepatocellular carcinoma suggests a new treatment strategy[J].Mol Pharmacol,2016,89(2):263-272.
    [2]PENG H,LI QL,HOU SH,et al.Association of genetic polymorphisms in CD8+T cell inhibitory genes and susceptibility to and progression of chronic HBV infection[J].Infect Genet Evol,2015,36:467-474.
    [3]THOLEY DM,AHN J.Impact of hepatitis C virus infection on hepatocellular carcinoma[J].Gastroenterol Clin North Am,2015,44(4):761-773.
    [4]CHEN S,WANG Y,RUAN W,et al.Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity[J].Oncol Lett,2014,8(5):2333-2339.
    [5]HO CT,SHANG HS,CHANG JB,et al.Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma[J].Oncotarget,2015,6(28):26104-26118.
    [6]ZHENG W,SAI W,YAO M,et al.Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma Hep G2/ADM cells[J].Tumour Biol,2015,36(5):3995-4003.
    [7]DONG ZZ,YAO M,WANG L,et al.Abnormal expression of insulin-like growth factor-Ⅰreceptor in hepatoma tissues and its inhibition promoting apoptosis of tumor cells[J].Tumor Biol,2013,34(6):3397-3405.
    [8]YAO NH,YAO DF,DONG ZZ,et al.Effects of inhibited IGF-ⅠR expression on proliferation and apoptosis of human hepatocellular carcinoma cell lines[J].Chin J Hepatol,2013,21(5):376-380.(in Chinese)姚宁华,姚登福,董志珍,等.足叶苦素抑制IGF-ⅠR表达对肝癌细胞增殖与凋亡的影响[J].中华肝脏病杂志,2013,21(5):376-380.
    [9]YAO M,YAN XD,WANG L,et al.Down-regulating insulinlike growth factor-Ⅰreceptor gene transcription on effect of hepatoma growth inhibition[J].Chin J Cancer Prev Treat,2015,22(19):1528-1533.(in Chinese)姚敏,严晓娣,王理,等.干扰IGF-ⅠR基因表达对肝癌细胞裸鼠移植瘤生长影响研究[J].中华肿瘤防治杂志,2015,22(19):1528-1533.
    [10]CHANG TS,WU YC,CHI CC,et al.Activation of IL6/IGFⅠR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression[J].Clin Cancer Res,2015,21(1):201-210.
    [11]XIANG Y,LIU Y,YANG Y,et al.A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines[J].Oncol Rep,2015,34(3):1249-1260.
    [12]ZHAO X,CHEN Q,LI Y,et al.Doxorubicin and curcumin codelivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice[J].Eur J Pharm Biopharm,2015,93:27-36.
    [13]FANTAPPIE O,SASSOLI C,TANI A,et al.Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane[J].J Cell Mol Med,2015,19(6):1410-1417.
    [14]XIANG QF,ZHANG DM,WANG JN,et al.Cabozantinib reverses multidrug resistance of human hepatoma Hep G2/adr cells by modulating the function of P-glycoprotein[J].Liver Int,2015,35(3):1010-1023.
    [15]YAN J,ZHOU Y,CHEN D,et al.Effects of mitochondrial translocation of telomerase on drug resistance in hepatocellular carcinoma cells[J].J Cancer,2015,6(2):151-159.
    [16]CHENG L,LUO S,JIN C,et al.FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway[J].Cell Death Dis,2013,4:e923.
    [17]YAN F,BAI LP,GAO H,et al.EGF reverses multi-drug resistance via the p-ERK pathway in Hep G2/ADM and SMMC7721/ADM hepatocellular carcinoma models[J].Asian Pac J Cancer Prev,2014,15(6):2619-2623.
    [18]WANG PP,XU DJ,HUANG C,et al.Reversal of human hepatic cancer multidrug resistance is induced by astragalosideⅡin BEL-7402/FU cells[J].Chin J Clin Pharmacol Ther,2014,19(2):139-144.(in Chinese)王培培,许杜娟,黄灿,等.黄芪皂苷Ⅱ对人肝癌多药耐药细胞BEL-7402/FU的逆转耐药作用[J].中国临床药理学与治疗学,2014,19(2):139-144.
    [19]SHEN J,SUN H,MENG Q,et al.Simultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNA[J].Mol Pharm,2014,11(10):3342-3351.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (315) PDF downloads(58) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return